Table 2.
Headache characteristics in patients with COVID-19 in Tunisia
| Total | With fever | Without fever | p value | |
|---|---|---|---|---|
| n = 279 | n = 143 (51.3%) | n = 136 (48.7%) | ||
| Time to appearance (median (IQR), days) | 1 (0–3) | 1 (0–2) | 1 (0–4) | 0.127 |
| Total duration (median (IQR), days) | 4 (2–7) | 4.25 (2.25–7) | 3.5 (2–7) | 0.202 |
| Attack duration (median (IQR), hours) | 3 (1–12) | 4 (2–24) | 2 (1–12) | 0.071 |
| Headache at onset (n (%)) | 219 (78.5) | 122 (85.3) | 97 (71.3) | 0.004 |
| Location (n (%)) | ||||
| - Frontal | 124 (44.4) | 67 (46.9) | 57 (41.9) | |
| - Generalized | 80 (28.7) | 39 (27.3) | 41 (30.1) | |
| - Bitemporal | 19 (6.8) | 10 (7.0) | 9 (6.6) | |
| - Occipital | 20 (7.2) | 9 (6.3) | 11(8.1) | |
| - Unilateral | 16 (5.7) | 8 (5.6) | 8 (5.9) | |
| - Variable | 13 (4.7) | 6 (4.2) | 7 (5.1) | |
| - Not specified | 7(2.5) | 4 (2.8) | 3 (2.2) | |
| Intensity (n (%)) | ||||
| - Mild or moderate | 165 (59.1) | 74 (51.7) | 91 (66.9) | 0.026 |
| - Severe | 110 (39.4) | 67 (46.9) | 43 (31.6) | 0.005 |
| - Not specified | 4 (1.4) | 2 (1.4) | 2 (1.5) | |
| Persistence of headache after recovery (n (%)) | 47 (16.8) | 26 (18.2) | 21 (15.4) | 0.404 |
| Consultation for headache (n (%)) | 15 (5.4) | 10 (7.0) | 5(3.7) | 0.199 |
Significant results have been italicized